Biomedical Engineering Reference
In-Depth Information
122. zur MuÈhlen, A.; Schwarz, C.; Mehnert, W. Solid Lipid Nanoparticles (SLN) for Controlled Drug
Delivery ± Drug Release and Release Mechanism.
Eur. J. Pharm. Biopharm.
1998,
45,
149-155.
123. Labhasetwar, V. Nanotechnology for Drug and Gene Therapy: The Importance of Understand-
ing Molecular Mechanisms of Delivery.
Curr. Opin. Biotechnol.
2005,
16,
674-680.
124. Cherukuri, P.; Bachilo, S. M.; Litovsky, S. H.; Weisman, R. B. Near-Infrared Fluorescence
Microscopy of Single-Walled Carbon Nanotunes in Phagocytic Cells.
J. Am. Chem. Soc.
2004,
126,
15638-15639.
125. Singh, R.; Pantarotto, D.; Lacerdo, L.; Pastorin, G.; Klumpp, C.; Prato, M.; Bianco, A.;
Kostarelos, K. Tissue Biodistribution and Blood Clearance Rates of Intravenously Adminis-
tered Carbon Nanotube Radiotracers.
Proc. Natl. Acad. Sci. U.S.A.
2006,
103,
3357-3362.
126. Moghimi, S. M.; Hunter, A. C.; Murray, J. C. Nanomedicine: Current Status and Future Pros-
pects.
FASEB J.
2005,
19,
311-330.
127. Nel, A.; Xia, T.; Madler, L.; Li, N. Tox Potential of Materials at the Nanolevel.
Science
2006,
311,
622-627.
128. Akerman, M. E.; Chan, W. C.; Laakkonen, P.; Bhatia, S. N.; Ruoslahti, E. Nanocrystal Target-
ing In Vivo.
Proc. Natl. Acad. Sci. U.S.A.
2002,
99,
12617-12621.
129. Ballou, B.; Lagerholm, B. C.; Ernst, L. A.; Bruchez, M. P.; Waggoner, A. S. Noninvasive
Imaging of Quantum Dots in Mice.
Bioconjug. Chem.
2004,
15,
79-86.
130. Gao, X.; Cui, Y.; Levenson, R. M.; Chung, L. W. K.; Nie, S. In Vivo Cancer Targeting and
Imaging with Semiconductor Quantum Dots.
Nat. Biotechnol.
2004,
22,
969-976.
131. Vasir, J.; Labhasetwar, V. Targeted Drug Delivery in Cancer Therapy.
Technol. Cancer Res.
Treat.
2005,
4
, 363-374.
132. Oh, P.; Li, Y.; Yu, J.; Durr, E.; Krasinka, K. M.; Carver, L. A.; Testa, J. E.; Schnitzer, J. E.
Subtractive Proteomic Mapping of the Endothelial Surface in Lung and Solid Tumours for
Tissue-Specific Therapy.
Nature
2004,
429,
629-635.
133. Murray, J. C.; Moghimi, S. M. Endothelial Cells as Therapeutic Targets in Cancer: New Biol-
ogy and Novel Delivery Systems.
Crit. Rev. Ther. Drug Carrier Syst.
2003,
20,
139-152.
134. Moghimi, S. M. Modulation of Lymphatic Distribution of Subcutaneously Injected Poloxamer
407-Coated Nanospheres: The Effect of the Ethylene Oxide Chain Configuration.
FEBS Lett.
2003,
540,
241-244.
135. Moghimi, S. M.; Bonnemain, B. Subcutaneous and Intravenous Delivery of Diagnostic Agents
to the Lymphatic System: Applications in Lymphoscintigraphy and Indirect Lymphography.
Adv. Drug Deliv. Rev.
1999,
37,
295-312.
136. Winter, P.; Caruthers, S. D.; Kassner, A.; Harris, T. D.; Chinen, L. K.; Allen, J. S.; Lacy, E. K.;
Zhang, H. Y.; Robertson, J. D.; Wickline, S. A. Molecular Imaging of Angiogenesis in Nascent
vx-2 Rabbit Tumours using a Novel Alpha(v) Beta(3)-Targeted Nanoparticle and 1.5 Tesla
Magnetic Resonance Imaging.
Cancer Res.
2003,
63,
5838-5843.
137. Kim, S.; Lim, Y. T.; Soltesz, E. G.; De Grand, A. M.; Lee, J.; Nakayama, A.; Parker, J. A.;
Mihaljevic, T.; Laurence, R. G.; Dor, D. M. Near-Infrared Fluorescent Type II Quantum Dots
for Sentinel Lymph Node Mapping.
Nat. Biotechnol.
2004,
22,
93-97.
138. Bergqvist, L.; Sundberg, R.; Ryden, S.; Strand, S. E. The “Critical Colloid Dose” in Studies of
Reticuloendothelial Function.
J. Nucl. Med.
1987,
28,
1424-1429.
139. Bradfield, J. W. A New Look at Reticuloendothelial Blockade.
Br. J. Exp. Pathol.
1980,
61,
617-623.
140. Cleland, J. L., Ed.;
Protein Delivery from Biodegradable Microspheres
; Plenum Press:
New York, 1997.
141. Molema, G.; de Leij, L. F. M. H .; Meijer, D. K. F. Tumor Vascular Endothelium: Barrier or
Target in Tumor Directed Drug Delivery and Immunotherapy.
Pharm. Res.
1999,
14,
2-38.
